Webinar
How to maximize asset value with a comprehensive evidence approach
calendar

March 10, 2022

Calendar
clock

9:00am - 12:00pm

(GMT-05:00)

Register

View all IQVIA events

Leveraging the potential of real world evidence (RWE) for emerging biopharma companies from early clinical development through commercialization to accelerate patient access to innovative treatments and increase investor returns.

What you will learn at the conference:

  • Discover how evidence strategies can maximize the value of your asset in terms of meeting cross-functional evidence needs of both your internal and external stakeholders.
  • As an investor, learn how RWE can serve as both a resource to support investment decision-making as well as a strategy for maximizing asset value
  • Understand the benefits of end-to-end RWE generation throughout the product lifecycle including:
    • pre-clinical - e.g. natural history of disease studies
    • clinical development - e.g. increase efficiencies and de-risk development plans
    • pre-launch regulatory engagement - e.g. use of RWE to complement trial data or serve as a comparator arm
    • market optimization needs post-launch - e.g. RWE for payer coverage considerations
  • Leverage innovative real world evidence generation approaches to create unique value propositions for rare disease, oncology and cell and gene therapy.
Contact Us